Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Pembrolizumab|RADIATION: Palliative radiotherapy
Sponsor: Dana-Farber Cancer Institute
Collaborators: Merck Sharp & Dohme LLC